Showing Results for
- Academic Journals (10,891)
Search Results
- 10,891
Academic Journals
- 10,891
-
From:European Journal of Clinical Nutrition (Vol. 59, Issue 1) Peer-ReviewedObjective:: To evaluate the prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer and create statistically distinct prognostic groups of colorectal cancer patients based on clinical...
-
From:Expert Review of Clinical Pharmacology (Vol. 6, Issue 1) Peer-ReviewedAuthor(s): Marilyn N Bulloch [*] 1 2 , Amber M Hutchison 2 Keywords : breakthrough cancer pain; fentanyl; intranasal; pectin For many patients with cancer, moderate-to-severe pain becomes an ever present and...
-
From:Personalized Medicine (Vol. 10, Issue 3) Peer-ReviewedAuthor(s): Darren R Tyson [*] 1 , Vito Quaranta 2 KEYWORDS : cancer therapeutics; dynamic treatment response; single-cell analysis; tumor heterogeneity Cancer has been considered a genetic disease for over a...
-
From:The Chronicle of Philanthropy (Vol. 25, Issue 07)Byline: Caroline Preston Since recovering from lung cancer in 1985, Greg Anderson has written more than a dozen books on holistic approaches to fighting cancer and built an international network of nonprofits to help...
-
From:Aging Health (Vol. 9, Issue 4) Peer-ReviewedAuthor(s): Roxanne E Jensen [*] 1 , Leigh Anne Faul 2 , Waddah B Al-Refaie 3 , Arnold L Potosky 4 Keywords * elderly; health services; oncology; quality of healthcare There are currently 13.7 million cancer...
-
From:Indian Journal of Cancer (Vol. 50, Issue 2) Peer-ReviewedByline: P. Pai, A. Vaidya, K. Prabhash, S. Banavali Context: Head and neck cancers in developing countries present with advanced disease, compounded by poor access to tertiary care centers. Aim: We evaluated oral...
-
From:Future Oncology (Vol. 9, Issue 8) Peer-ReviewedAuthor(s): Trijn Israels 1 , Mhamed Harif 2 , Kathy Pritchard-Jones [*] 3 Keywords * Africa; low-income countries; nephroblastoma; Wilms tumor Wilms tumor is a relatively common and curable childhood renal...
-
From:MPR Hematology and Oncology Edition (Vol. 6, Issue 3)MPR is pleased to include up-to-date cancer treatment regimens with every issue of our Hematology & Oncology edition. Find these treatment regimens and additional updates at ChemotherapyAdvisor.com. Just click on...
-
From:Indian Journal of Cancer (Vol. 50, Issue 3) Peer-ReviewedByline: PS. Amare, V. Gadage, H. Jain, S. Nikalje, S. Manju, N. Mittal, S. Gujral, R. Nair Background: The present study of 238 B-cell Chronic Lymphocytic Leukemia (B-CLL) patients were undertaken to seek the...
-
From:Pharmacogenomics (Vol. 14, Issue 13) Peer-ReviewedAuthor(s): Gregorio Antonio Alcazar-González 1 , Ana Laura Calderón-Garcidueñas 2 , María Lourdes Garza-Rodríguez 3 , Gabriela Rubio-Hernández 4 , Sergio Escorza-Treviño 5 , Estibaliz Olano-Martin 6 , Ricardo Martín...
-
From:Expert Review of Proteomics (Vol. 10, Issue 5) Peer-ReviewedAuthor(s): Angelo D'Alessandro 1 , Lello Zolla [*] 2 Keywords : cancer; drug development; mass spectrometry; metabolism; proteomics Metabolomics, the new/old hallmark of cancer Human tumor pathogenesis is...
-
From:Pharmacogenomics (Vol. 15, Issue 1) Peer-ReviewedAuthor(s): Jai N Patel 1 KEYWORDS : biomarkers; cancer; genetics; genotype; pharmacogenetics; therapy; tumors The clinical problem The genome of cancer cells differs slightly, albeit in a significant...
-
From:MPR Hematology and Oncology Edition (Vol. 7, Issue 1)OVARIAN CANCER TREATMENT REGIMENS Principle of therapy: All regimens involving primary chemotherapy/ primary adjuvant therapy include intravenous (IV) and intraperitoneal (IP) options, and may be used for epithelial...
-
From:Immunotherapy (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): Christof Seidl aff1 Keywords: * [alpha]-emitter; antibody; radioimmunotherapy; radionuclide; targeted therapy Background Radionuclides that emit [alpha]- or [beta]-particles exhibit a high...
-
From:Oncology (Vol. 28, Issue 9) Peer-ReviewedSince the late 1890s, when morphologic tumor heterogeneity was first described by pathologists, tumor heterogeneity has been recognized as an important and relevant clinical problem. From the discovery of tumor...
-
From:Oncology (Vol. 28, Issue 9) Peer-ReviewedThe common term "chemobrain" belies the complex nature of the problem of changes in cognitive function experienced by patients with cancer. [1] Multiple factors contribute to these cognitive changes. Moreover, some...
-
From:Journal of Asian Medical Student Association (Vol. 2, Issue S2) Peer-ReviewedNatural products have been the targets for cancer therapy for several years but there is still a dearth of information on potent compounds that may protect normal cells and selectively destroy cancerous cells. This...
-
From:Epigenomics (Vol. 6, Issue 3) Peer-ReviewedAuthor(s): Peter Birk Rasmussen aff1 aff2 , Peter Staller [*] aff1 Keywords: cancer; enzymatic inhibitors; epigenetics; gene transcription; H3K4 methylation; histone demethylase; jumonji; oncogenes The KDM5...
-
From:Nature Medicine (Vol. 21, Issue 5) Peer-ReviewedResistance to cancer therapies presents a significant clinical challenge. Recent studies have revealed intratumoral heterogeneity as a source of therapeutic resistance. However, it is unclear whether resistance is...
-
From:Immunotherapy (Vol. 7, Issue 4) Peer-ReviewedAuthor(s): Tracy L Putoczki aff1 , Matthias Ernst [*] aff1 aff2 Keywords: cancer; GP130; IL-11; IL-6; inflammation; STAT3; therapy Background IL-11 is a member of the IL-6 family of cytokines, which includes...